TXNIP and Alzheimer disease: In addition, it was demonstrated in a mutant tau mouse model of AD that addition of verapamil, a calcium channel blocker, significantly downregulated the levels of TXNIP, which correlated with reduction in the levels of tangle-associated phosphorylated tau [17].